0
0
9/22/23 at 8:26pm
Organization
Nikkei.com
Author
Staff Writer
28 words
0
Comments
Eisai-Biogen treatment clears fast-track review after U.S. green light in August
You are the first to view
https://asia.nikkei.com/Business/Pharmaceuticals/Japan-set-to-approve-Alzheimer-s-drug-Leqembi-as-soon-as-Monday
Create an account
or login to join the discussion